ANXIOLYTICS - PATENT ANALYSIS 1990-1995

Anxiety disorders include generalised anxiety disorders, panic disorde rs and obsessive-compulsive disorders. Patients suffer chronic and per sistent apprehension and tension not relating to any real danger and t his causes physical symptoms which interfere with everyday activities. Benzodiazepines were widely used but have a serious side-effect profi le, so newer anxiolytic drugs are required. This review highlights the patent activity, drugs in development and the leading pharmaceutical companies in this area over the period 1990 through to 1995.